Apr 12th Presentation
Here is a copy of Tom’s presentation. Feel free to learn more and obtain his contact info at www.icemiller.com
Apr 12th: Intellectual Property for Startups Including Innovative Approaches
Life Science companies can strategically use patent protection to help raise funding, extend exclusivity in the marketplace, and guide future R&D. An Intellectual Property (IP) strategy is one of the first critical components to commercializing technology through a startup or licensing. Join us for an open discussion on IP with members of Ice Miller’s Intellectual Property team. This is the perfect time to ask the experts about protecting your technology.
Speaker:Tom Walsh, Intellectual Property Group, Partner, Ice Miller LLP.
Tom Walsh is a member of Ice Miller’s Intellectual Property Group. He assists with the intellectual property issues facing new companies and established businesses. His experience includes patent prosecution in a variety of technology areas, licensing, intellectual property strategies, technology transactions, trademarks, and franchising.
When: April 12th, 2011 5-7pm
Where: Riley Outpatient Center
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
RSVP: https://www.formstack.com/forms/?998004-5CIlxUOPrZ
Mar 8th: Building Your Professional Network w/ Dr. Joerg Schreiber
Dr. Schreiber will be discussing the value of building a network to help move you research, business, and career forward. Commercializing a technology requires knowing and finding excellent people and companies. Dr. Schreiber has expanded his network through being on the boards of the Indiana Health Industry Forum, the IUPUI School of Engineering, the Indiana chapter of the International Council on Systems Engineering, Rose Hulman, EDF Ventures, and several life science startups.
Join us and learn more on how you can grow and leverage your network to effectively get things done.
Speaker: Joerg Schreiber, Ph.D., President, White Arrow Consulting
When: Mar 8th, 2011 5-7pm
Where: Riley Outpatient Center
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
RSVP: http://www.ihif.org/conference/register/35
Dr. Schreiber joined Roche Diagnostics (previously Boehringer Mannheim Germany) in 1986 and moved to the US in 1994. He held several functions in R&D (analytics, process development) and Operations (quality system, purchasing), before he assumed responsibility for the business unit R&D in the US organization in 1996. Being responsible for a multi-project pipeline where project teams are in different locations as well as come from different cultures, it was imperative, not only to continuously improve the development philosophy and tools, but also to work consistently with the information and knowledge created across all projects in the pipeline. In 2001 Dr.Schreiber accepted the position of VP R&D and Business Development for a newly created business, MyDoc.com, wherein Roche Diagnostics built an internet-based medical practice. In his latest endeavor for Roche Diagnostics Dr. Schreiber commercialized technology, which Roche Diagnostics was not using actively, to create more value and to benefit the Central Indiana Region.
Being conscious of the fact that knowledge and people contribute vastly to the success of R&D and business in general, Dr. Schreiber is a strong promoter of Knowledge Management in all endeavors and has experimented repeatedly to find optimal ways to create a knowledge creating and sharing culture and to support the necessary underlying tool structure. While at Roche, he co-chaired the Roche Diagnostics Knowledge Board promoting Knowledge Management company wide.
After his retirement from Roche, Dr. Schreiber works as Business Development consultant in the Life Sciences and has joined the Boards of The Cientive Group Inc. and AION Diagnostics, which he chairs. He has founded and uses as his business platform White Arrow Consulting LLC (www.whitearrowconsulting.com). From 2005 to 2007 he worked with Quadraspec Inc. as Chief Operating Officer. From 2007 to 2010, he worked with Physical Logic AG as VP R&D, CEO, and Director of its Diabetes Business Unit. Currently, he serves as CEO of Access Health Wealth.
Dr. Schreiber holds a Ph.D. in physics from Giessen University, Germany, specialized in biophysics and was a post doc at the National Institute for Environmental Health Sciences in Research Triangle Park, NC, USA.
He was a board member of the Center for Enterprise Leadership at the Boston University and the Connectivity Industry Consortium, is Chairman of the Indiana Health Industry Forum and holds several other board positions in professional, civic, and art organizations, where he continues to work in an interdisciplinary context.
Feb 8th: Keith March – Inventions at the Bedside
Join in a discussion around strategies to develop inventions in a clinical setting that can change healthcare while creating commercializable technologies. Dr. March will also speak about his experiences as a internationally recognized researcher, and inventor.
IU School of Medicine
Professor of Medicine; Cryptic Masons Medical Research Foundation Prof
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
Keith L. March, MD, PhD
§ Professor, Departments of Medicine, Cellular and Integrative Physiology, and Biomedical Engineering, Indiana University School of Medicine and the Krannert Institute of Cardiology
§ Director, Indiana Center for Vascular Biology & Medicine (ICVBM)
§ Director, IUPUI Vascular and Cardiac Center of Adult Stem Cell Therapy (VC-CAST)
§ Director, VA Center for Regenerative Medicine
Keith March has dedicated his career to bringing new medical approaches to patients. His publications include more than 100 manuscripts. He was the editor of the first book dedicated to cardiovascular gene transfer. Dr. March’s research has resulted in more than 40 worldwide (19 U.S.) patents, with others pending. He invented the Closer, a widely-utilized patented suture-mediated closure device, used to close the puncture wound in an artery following heart catheterization. This device allows a patient to “walk off the table” after a catheterization without requiring prolonged bedrest. Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology in 1999 and the Closer approach is used annually worldwide in 500,000 patients. He has served as a scientific advisor to numerous pharmaceutical, biotechnology and medical device companies.
His laboratory focuses on vascular biology, with a particular emphasis on the function and translational study of CD34+ stem cells found in the adipose tissue, which his laboratory identified as peri-vascular cells with critical roles in vasculogenesis, angiogenesis, and adipose tissue regulation. Dr. March is recognized as a leading expert in the field of adult stem cell research, particularly that involving adipose-derived stromal stem cells. In 2008, he became chair of the NIH/NHLBI DSMB that oversees cell therapy trials in the areas of heart, lung, and blood diseases.
In addition to his research roles, Dr. March has served as the president (2007) of the International Federation of Adipose Therapeutics and Science (IFATS); and serves as the Chief Medical Advisor for the Cell Therapy Foundation. In both affiliations, he has worked to advance collaboration as well as awareness about the significance of adult stem cells.
Jan 11th: Keith March – Inventions at the Bedside
Join in a discussion around strategies to develop inventions in a clinical setting that can change healthcare while creating commercializable technologies. Dr. March will also speak about his experiences as a internationally recognized researcher, and inventor.
IU School of Medicine
Professor of Medicine; Cryptic Masons Medical Research Foundation Prof
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
Keith L. March, MD, PhD
§ Professor, Departments of Medicine, Cellular and Integrative Physiology, and Biomedical Engineering, Indiana University School of Medicine and the Krannert Institute of Cardiology
§ Director, Indiana Center for Vascular Biology & Medicine (ICVBM)
§ Director, IUPUI Vascular and Cardiac Center of Adult Stem Cell Therapy (VC-CAST)
§ Director, VA Center for Regenerative Medicine
Keith March has dedicated his career to bringing new medical approaches to patients. His publications include more than 100 manuscripts. He was the editor of the first book dedicated to cardiovascular gene transfer. Dr. March’s research has resulted in more than 40 worldwide (19 U.S.) patents, with others pending. He invented the Closer, a widely-utilized patented suture-mediated closure device, used to close the puncture wound in an artery following heart catheterization. This device allows a patient to “walk off the table” after a catheterization without requiring prolonged bedrest. Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology in 1999 and the Closer approach is used annually worldwide in 500,000 patients. He has served as a scientific advisor to numerous pharmaceutical, biotechnology and medical device companies.
His laboratory focuses on vascular biology, with a particular emphasis on the function and translational study of CD34+ stem cells found in the adipose tissue, which his laboratory identified as peri-vascular cells with critical roles in vasculogenesis, angiogenesis, and adipose tissue regulation. Dr. March is recognized as a leading expert in the field of adult stem cell research, particularly that involving adipose-derived stromal stem cells. In 2008, he became chair of the NIH/NHLBI DSMB that oversees cell therapy trials in the areas of heart, lung, and blood diseases.
In addition to his research roles, Dr. March has served as the president (2007) of the International Federation of Adipose Therapeutics and Science (IFATS); and serves as the Chief Medical Advisor for the Cell Therapy Foundation. In both affiliations, he has worked to advance collaboration as well as awareness about the significance of adult stem cells.
See you January 11th! Sign up for our mailing list to get updates.
Hey Everyone!
Due to a few conflicts we have to skip our November meeting.
In the meantime make sure you are signed up for our mailing list, and mark your calendars for Jan 11th.
HAPPY HOLIDAYS!
Oct 12th: Speaker Update
Unfortunately Dr. James Spahn had a conflict and will have to postpone his presentation at IBEN.
BUT, fortunately some of the great successes that have recently unfolded at Xylogenics, along with their accelerated business model, make Mike Neibler, the CEO an ideal speaker.
You can still use the same registration link in the previous post.
See you tomorrow, and bring a friend!
Oct 12th: Life Sciences Opportunities Beyond Therapeutics and Diagnostics
Indianapolis is ripe with business opportunities in the Life Sciences outside of the blockbuster therapeutics and diagnostics. Come join us and learn how two entrepreneurs have founded unique businesses that address market needs without the high profile risk.
Speakers:
Vaidya Subramaniam, Owner, PowerHouse Proteomic Systems
Dr. James Spahn, Founder, EHOB & WoundVision
When: Oct 12th 5-7PM
Where: Riley Outpatient Center
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
Join Our Mailing List
No Spam, No Frills, Just Meeting announcements.
 |
| Subscribe to IBEN – Indiana Biomedical Entrepreneur Network |
| Visit this group |
Sept. 14th: State of the Industry
Come join us to kick off the new season with our annual state of the industry. Learn about trends in research commercialization and funding that will affect the strategy of your current business, a business you are thinking of starting, or research that you think may eventually be commercialized.
Speakers:
Brian Stemme, Project Director, BioCrossroads
Matt Neff, President & CEO, Clarian Health Ventures
When: Sept 14th 5-7PM
Where: Riley Outpatient Center
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building (cash only). After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
RSVP: RSVP by sending an email to ibensteering@gmail.com with “Sept. 14th RSVP”
Soon we will have a new RSVP system up. Thanks, and see you on the 14th!